AAAAAA
Results:
1-11
|
Results: 11
Authors:
Butler, LM
Webb, Y
Agus, DB
Higgins, B
Tolentino, TR
Kutko, MC
LaQuaglia, MP
Drobnjak, M
Cordon-Cardo, C
Scher, HI
Breslow, R
Richon, VM
Rifkind, RA
Marks, PA
Citation: Lm. Butler et al., Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase, CLIN CANC R, 7(4), 2001, pp. 962-970
Authors:
Huang, J
Agus, DB
Winfree, CJ
Kiss, S
Mack, WJ
McTaggart, RA
Choudhri, TF
Kim, LJ
Mocco, J
Pinsky, DJ
Fox, WD
Israel, RJ
Boyd, TA
Golde, DW
Connolly, ES
Citation: J. Huang et al., Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke, P NAS US, 98(20), 2001, pp. 11720-11724
HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer
Authors:
Agus, DB
Bunn, PA
Franklin, W
Garcia, M
Ozols, RF
Citation: Db. Agus et al., HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer, SEMIN ONCOL, 27(6), 2000, pp. 53-63
Authors:
Agus, DB
Akita, RW
Fox, WD
Lofgren, JA
Higgins, B
Maiese, K
Scher, HI
Sliwkowski, MX
Citation: Db. Agus et al., A potential role for activated HER-2 in prostate cancer, SEMIN ONCOL, 27(6), 2000, pp. 76-83
Authors:
McDonald, S
Brive, L
Agus, DB
Scher, HI
Ely, KR
Citation: S. Mcdonald et al., Ligand responsiveness in human prostate cancer: Structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors, CANCER RES, 60(9), 2000, pp. 2317-2322
Authors:
Amler, LC
Agus, DB
LeDuc, C
Sapinoso, ML
Fox, WD
Kern, S
Lee, D
Wang, V
Leysens, M
Higgins, B
Martin, J
Gerald, M
Dracopoli, N
Cordon-Cardo, C
Scher, HI
Hampton, GM
Citation: Lc. Amler et al., Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R, CANCER RES, 60(21), 2000, pp. 6134-6141
Authors:
Butler, LM
Agus, DB
Scher, HI
Higgins, B
Rose, A
Cordon-Cardo, C
Thaler, HT
Rifkind, RA
Marks, PA
Richon, VM
Citation: Lm. Butler et al., Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo, CANCER RES, 60(18), 2000, pp. 5165-5170
Authors:
Agus, DB
Cordon-Cardo, C
Fox, W
Drobnjak, M
Koff, A
Golde, DW
Scher, HI
Citation: Db. Agus et al., Prostate cancer cell cycle regulators: Response to androgen withdrawal anddevelopment of androgen independence, J NAT CANC, 91(21), 1999, pp. 1869-1876
Authors:
Moskowitz, CH
Bertino, JR
Glassman, JR
Hedrick, EE
Hunte, S
Coady-Lyons, N
Agus, DB
Goy, A
Jurcic, J
Noy, A
O'Brien, J
Portlock, CS
Straus, DS
Childs, B
Frank, R
Yahalom, J
Filippa, D
Louie, D
Nimer, SD
Zelenetz, AD
Citation: Ch. Moskowitz et al., Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3776-3785
Authors:
Agus, DB
Scher, HI
Higgins, B
Fox, WD
Heller, G
Fazzari, M
Cordon-Cardo, C
Golde, DW
Citation: Db. Agus et al., Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models, CANCER RES, 59(19), 1999, pp. 4761-4764
Authors:
Agus, DB
Vera, JC
Golde, DW
Citation: Db. Agus et al., Stromal cell oxidation: A mechanism by which tumors obtain vitamin C, CANCER RES, 59(18), 1999, pp. 4555-4558
Risultati:
1-11
|